Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01098851 · ClinicalTrials.gov registry record

Oxygen Saturation Monitoring During Surgery

A clinical trial of Sleep Apnea, Obstructive, sponsored by Medtronic - MITG.

Completed
Registry status
21
Enrollment target
1
Study location

NCT01098851: Completed study of Sleep Apnea, Obstructive, sponsored by Medtronic - MITG.

NCT01098851 is a study of Sleep Apnea, Obstructive that has completed, run by Medtronic - MITG. The registered enrollment target is 21 participants, below the 262-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01098851, a study of Sleep Apnea, Obstructive, has completed, sponsored by Medtronic - MITG.

COMPLETED
Registry status
21 participants
Enrollment target
1
Study location

Study Summary

Patients with Obstructive Sleep Apnea (OSA) have cyclical patterns of lower blood oxygen during sleep because of repeated episodes of upper airway obstruction that cause their breathing to stop. When these patients have surgery, anesthetic drugs may worsen these patterns of lower blood oxygen. This study monitors ten patients at high risk for OSA and ten patients at low risk for OSA during surgery. Patterns of lower oxygen saturations should arise in the high risk group but not the low risk group.

Primary Outcome

Saturation Pattern Detection (SPD) is the pattern of oxygen saturation values plotted against time that occurs when patients have cyclical reduced air movement during breathing. Their blood oxygen level decreases and increases as they slow and increase their breathing.

Conditions Studied

Sleep Apnea, Obstructive

Study Locations (1)

Colorado

  • Avista Adventist Hospital - Louisville

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2009-07
Est. Completion 2009-11
Medtronic - MITG

119 total trials

What the finished NCT01098851 record still lists

NCT01098851 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 262-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (92% lower).

The record links to 1 condition, with Sleep Apnea, Obstructive appearing as the primary indexed condition, and to 0 interventions.

NCT01098851 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT01098851 about?

NCT01098851 is a clinical study titled "Oxygen Saturation Monitoring During Surgery". Patients with Obstructive Sleep Apnea (OSA) have cyclical patterns of lower blood oxygen during sleep because of repeated episodes of upper airway obstruction that cause their breathing to stop. When these patients have surgery, anesthetic drugs may worsen these patterns of lower blood oxygen. This ...

What is the current status of trial NCT01098851?

This trial is currently completed. The enrollment target is 21 participants. The study started on 2009-07. Estimated completion is 2009-11.

What conditions does trial NCT01098851 study?

This clinical trial studies the following conditions: Sleep Apnea, Obstructive.

Who is sponsoring clinical trial NCT01098851?

This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01098851 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Sleep Apnea, Obstructive

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01098851's enrollment target sits among peer trials

21 39th of 45 higher than 7 of 45 other Sleep Apnea, Obstructive trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sleep Apnea, Obstructive trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02447874 · 21 participants · Phase 1

    Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

  • NCT03826992 · 21 participants · Phase 1

    Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

  • NCT04107077 · 21 participants · Phase 2

    Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

  • NCT04158635 · 21 participants · Phase 1

    Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT01098851, the US trial registry maintained by the National Library of Medicine. NCT01098851 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.